2018
DOI: 10.1016/j.ijbiomac.2018.07.096
|View full text |Cite
|
Sign up to set email alerts
|

Spirulina maxima peptides suppress mast cell degranulation via inactivating Akt and MAPKs phosphorylation in RBL-2H3 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
1

Year Published

2019
2019
2025
2025

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 19 publications
0
11
1
Order By: Relevance
“…Previous studies demonstrated that the formation of ROS and NLRP3 activation have been involved in mast cell degranulation. Degranulation is the process of releasing mediators (histamine and β-Hexosaminidase) from the secretory granules within mast cells . Histamine and β-Hexosaminidase are presynthesized within mast cells and are degranulated by mast cells to release extracellular and other mediators involved in allergic reactions .…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies demonstrated that the formation of ROS and NLRP3 activation have been involved in mast cell degranulation. Degranulation is the process of releasing mediators (histamine and β-Hexosaminidase) from the secretory granules within mast cells . Histamine and β-Hexosaminidase are presynthesized within mast cells and are degranulated by mast cells to release extracellular and other mediators involved in allergic reactions .…”
Section: Discussionmentioning
confidence: 99%
“…Activation of protein tyrosine kinases is the earliest detectable signaling response to FcεRI cross-linking on mast cells [26]. Upon tyrosine kinase activation, molecular mechanisms involving the Src family kinase Lyn [30] and/or intracellular signaling via MAPKs [26, 31] promotes mast cell degranulation. Mast cell activation inhibitors, including the corticosteroid dexamethasone [21], have been shown to suppress mast cell activation by down-regulating signaling pathways.…”
Section: Discussionmentioning
confidence: 99%
“…Previous demonstrations showing that palbociclib can inhibit neoplastic mast cell proliferation [49] did not indicate whether palbociclib also inhibits mast cell activation, and specifically cell degradation, a key allergic disease treatment target. Hence, given palbociclib’s CDK inhibitory actions and its ability to suppress signaling molecule expression and/or activation, we hypothesize that palbociclib administered at a low-cytotoxicity dose may exert anti-IgE-mediated allergy effects by down-regulating of MAPK and/or NF-κB signaling downstream of CDK6 inhibition via FcεRI, whose activation may be modulated by the Src family kinase Lyn [30]. Lyn, interacting with FcεRIβ, is indispensable for FcεRI-mediated human mast cell activation, and specific inhibition of Lyn signaling may represent a new therapeutic strategy for the treatment of human allergic diseases [50].…”
Section: Discussionmentioning
confidence: 99%
“…To further verify the relationship between Pts and LKB1/AMPK and FcεRI signaling, we used siRNA to knockdown LKB1. Akt is observed to be activated in response to IgE in mast cells . It has been reported that Pts reduces acetaminophen-induced liver injury by activating the AMPK/Akt pathway .…”
Section: Discussionmentioning
confidence: 99%